Connect with us

Cannabis News

Wisconsin GOP Lawmakers Are Divided On How To Regulate Hemp THC Products

Published

on

“We would like to work together … to make sure – in my humble opinion – that we protect our constituents, but also I think it’s necessary to protect an industry.”

Isiah Holmes, to the Wisconsin Examiner

Wisconsin lawmakers are pushing for competing visions for the state’s hemp future.

One proposal, (SB 682), was discussed at Thursday’s meeting of the Senate Agriculture and Revenue Committee.

The bill would create a regulatory framework for hemp-derived cannabis products that would keep the state’s hemp industry afloat despite a federal ban that takes effect in November. Without state intervention, or the federal government choosing to reverse course, hemp growers and distributors fear Wisconsin’s $700 million industry and about 3,500 jobs will disappear.

Sen. Patrick Testin (R-Stevens Point), chairman of the Agriculture and Revenue Committee, introduced the bipartisan hemp bill to his committee, which he authored with bipartisan support.

Testin’s legislation would define hemp as any cannabis plant that contains no more than 0.3 percent delta-9 THC (or the maximum concentration allowed by federal law of up to 1 percent, whichever is greater) and would define “hemp-derived cannabinoids” as compounds extracted from the hemp plant. THC concentrations would be determined using specific high-throughput test methods.

The bill would require Wisconsinites to be at least 21 years old to purchase hemp-derived cannabinoid products, which would require the products to undergo independent laboratory testing to ensure they contain the amount and type of cannabinoids described on the product label. This practice, known as true labeling, is something the hemp industry has called for in recent years.

The products could not be sold based on the invoice including contact information for the manufacturer or brand owner, serving sizes for each container of the product, including allergens, ingredient lists, labeled potency in milligrams, and required warnings. According to the bill, hemp-derived products could not contain more than 10 milligrams of THC in a single serving.

Testin said Thursday that the industrial hemp market was worth about $11 billion in 2025, and would grow to $48 billion by 2032.

In Wisconsin, such products are “generally allowed legally but unregulated,” Testin said.

“There is no state law that restricts sales to minors, regulates the potency or content of (hemp-derived cannabinoid products), or imposes labeling or packaging requirements.” Minnesota, Kentucky, Tennessee and other states have enacted their own regulations, Testin said. “Regulations are needed (to remove the current uncertainty about the cannabinoid status of hemp-derived products), to provide stability and certainty to companies looking to enter this segment of the economy, and to enforce public safety regulations.”

Testin and Republican Rep. Tony Kurtz (R-Wonewoc) have worked on hemp laws for Wisconsin since the federal Farm Bill passed in 2018.

“I actually grew hemp,” Kurtz said, recalling that in 2019 “it was kind of an open market.”

Kurtz and others who called him “bad actors” also rode the hemp wave throughout the hearing, seeing it as a “get-rich-quick scheme.” Kurtz said the hemp industry today is full of people who want to do the right thing, but the “bad actors” have persisted.

said Kurtz SB 682 It’s designed so Wisconsinites “know they’re getting the best product and what they’re getting.”

“If we do nothing, hemp will be illegal at the federal level … but it’s still going to be legal here in the state of Wisconsin. So it’s in our best interest to work together, to get a good compromise, to get some common sense legislation to make sure that — in my humble opinion — we protect our constituents, but also I think it’s necessary to protect an industry.”

While hemp would be illegal at the federal level, a state-level industry could operate similarly to the way some states have recreational or legalized cannabis programs, largely because the federal government has not cracked down on these industries.

Testin added, “Regardless of anyone’s thoughts on cannabis and cannabinoids, it’s here. And obviously, we have a lot of different perspectives on how we should move forward.”

He repeatedly blasted the “stupidity” of what he described as “our gentlemen” in Washington DC, but also criticized other hemp-related bills in Wisconsin. While some Republicans want to ban hemp products outright, others have different ideas about how a legal industry should be regulated.

Bill introduced by Sen. Eric Wimberger (R-Oconto). SB 681It would require licenses for manufacturers and distributors of hemp-derived cannabinoid products. The products would be sold under a three-tier system and would be regulated like alcohol under the Division of Alcoholic Beverages, a component of the Department of Revenue, which would be renamed the Division of Intoxicating Products.

Although Testin and Wimberger’s bill have garnered bipartisan support, Testin described Wimberger’s bill as a “dead bill” and “more dead than dead.”

Testin argued that SB 681 would over-regulate the hemp industry and lead to a monopolization effect where a small number of entities control who gets hemp permits, creating a competitive market and acting as a “good boys’ club.”

Sen. Sarah Keyeski (D-Lodi) highlighted the division among state Republicans over hemp and cannabis products, noting that Democrats are not the ones who support legalization and regulation.

The committee room was filled with people from across the hemp industry who listened to the conversation. When lawmakers asked how to ensure children don’t get intoxicating cannabis products, distributors and manufacturers pointed to age-verification software even for online sales, which require a photo and image of a driver’s license to accept an order.

Marketing of children’s products using cartoon-like advertising and attractive candy wrappers was discussed.

Some veterans have testified how hemp has helped them relieve pain, kick addictive pain killers, soothe PTSD symptoms, and help them relax their bodies to sleep.

Other testimony focused on the risk of crossing state lines into Michigan or Illinois to obtain cannabis to treat various medical conditions.

Hemp farmers insist they now need to know how a federal ban will affect them as they decide when or if to plant this spring.

Much of the public testimony was in favor of Testin’s bill, although some speakers said it should protect farmers and growers and expand the types of products to include beverages and gummies.

“Yes, we are now in a scenario where there are intoxicating hemp products,” Testin said. “But not just anything like beer, wine or alcohol, we need to put some sensible regulations in place, which is what this bill aims to do.”

“In terms of concerns about smoking or getting fat from these products,” Testin added, “it’s no different than people consuming too much stale fish fry or drinking too much beer on a Friday night. It’s one’s choice and responsibility, but at the same time, making sure we have some regulations in place.”

The hemp industry deserves to “grow and grow,” Testin said, adding that the public deserves protection and knowing that “this stuff isn’t falling into the hands of people it shouldn’t be, like children.”

This story was first published by the Wisconsin Examiner.

Brendan Cleak’s photo.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Speakeasy Dispensary announces opening of newest Kentucky location

Published

on

By

Speakeasy Dispensary will officially open its newest medical cannabis location in Kentucky at 108 E. Main St., Princeton, KY 42445, further expanding access to patients in Caldwell County and surrounding communities.

The dispensary will open at 11:00 a.m. on Friday, April 10 for registered medical cannabis patients.

Located in the heart of downtown Princeton, the space reflects Speakeasy’s vision to blend local character and a comfortable, patient-first experience. The carefully designed environment provides a welcoming entrance before patients enter the main sales floor, where trained team members provide personalized guidance and education tailored to the individual’s needs.

“Each new location is an opportunity to meet patients where they are,” said Casey Flippo, CEO of Gold Leaf Management. “Communities like Princeton are an important part of Kentucky’s medical cannabis program, and expanding access here means more patients can explore safe and regulated options closer to home. As the program continues to take shape, our focus remains on building something reliable, accessible and rooted in long-term care.”

Opening weekend will feature a low-cost patient drive, offering new and existing patients an affordable and streamlined way to obtain or renew their Kentucky cannabis license.

© Speakeasy Dispensary

In partnership with the Kentucky Cannabis Industry Association and LexMed & Wellness, patient tours will be held Friday, April 10th from 11:00am to 7:00pm and Saturday, April 11th from 11:00am to 5:00pm. Appointments will be made with a licensed provider in a mobile unit on site, so patients can complete the entire process, including assessment, notary and state filing, in one visit.

Patients can register for an appointment by clicking here. The appointment fee is $25, and an additional $25 state fee must be paid when submitting documents to the state portal. The $25 state fee is waived for anyone who received a valid medical card in 2025.

As Kentucky’s medical cannabis market continues to develop, product availability and selection will continue to grow along with additional growers and processors entering the space. In addition to flowers and gummies, Speakeasy Princeton plans to have an extensive menu soon after opening, which will include vapes and concentrates, along with a new variety of gummies. Speakeasy continues to focus on providing a consistent education-first experience supported by strong statewide partnerships.

For more information:
Speakeasy Dispensary
speakeasydispensaries.com/

Continue Reading

Cannabis News

West Virginia Treasurer Allocates Medical Marijuana Revenue Despite Governor’s Veto

Published

on

By

“The issue is not whether the funds should be used, but how they are used and how we are doing it in a responsible and sustainable way.”

By Henry Culvyhouse, Mountain State Spotlight

This story was originally published by Mountain State Spotlight. Get stories like this delivered to your email inbox once a week; sign up for the free newsletter at https://mountainstatespotlight.org/newsletter.

Even with the veto he could have delayed it further $38 million spent on medical marijuana raised over the past four years, state Treasurer Larry Pack (R) now says he will release the funds during his original term.

Last week, Gov. Patrick Morrisey (R) vetoed a bill that would have required the release of medical marijuana funds to help the homeless and expedite child abuse and neglect cases in the court system. He said the bill tied up money for future expenses.

In his veto letter, Morrisey wrote, “West Virginia needs to do a better job of planning for the future, and cannot fully pre-commit future revenue like this if it has reserves to invest more in roads, water, sewer, site selection, rail and future tax cuts.”

Morrisey said he was willing to negotiate with the Legislature on how to spend the money.

“The issue is not whether the funds should be used, but how they are used and whether we are doing so responsibly and sustainably,” Lars Dalseide, a spokesman for the governor’s office, wrote in an email.

But the money was pre-committed in state code.

Pack’s office said 100 percent of that money will go to various offices and programs mandated by the original law; more than half to the Office of Medical Cannabis, with the remaining funds split between the substance abuse treatment grant program and law enforcement grants. The move negates the governor’s desire to use future reserves to deal with infrastructure and tax cuts.

In October, a Mountain State Spotlight investigation revealed that $34 million was deposited into an account held by the Treasury Department from the state’s medical marijuana program..

Pack’s office said the money it was not spent due to legal concerns about the drug. Currently, marijuana is listed as a Schedule I narcotic under federal law, meaning it has no medical use and is illegal.

Pack is not the first state treasurer to express concern. State Treasurer John Perdue (D) said his office would not keep money in 2018 after the Medical Cannabis Act was passed. Riley Moore (R), who beat Perdue in the 2020 race, never released the money.

In the 2026 Legislative Session, Del. Rep. Evan Worrell, R-Cabell, said he read a report on the funds raised and wanted to change it. He successfully led a bill that would have forced the state to spend money on a commission to help thousands of children with abuse and neglect in court and homelessness services.

Had the governor not vetoed the bill, the money would have been earmarked for one year for those things. The commission on substance abuse research, treatment, and abuse and neglect would continue for years to come.

Treasurer’s Office spokeswoman Carrie Smith said that due to the complexity of state and federal laws, the office had been working for months to release the money. He said that the money has been sent to the Department of Security and the Department of Health.

This the article appeared for the first time The focus of the Mountain State and is republished here under a Creative Commons Attribution-NoDerivs 4.0 International License.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Critical updates for cannabis taxpayers as the 2025 filing deadline approaches

Published

on

By











With the April 2025 tax return filing deadline fast approaching, cannabis companies must once again face the burden of Section 280E of the Internal Revenue Code (“Section 280E”). Despite significant developments over the past year — including a major executive order from President Trump and the IRS, for the first time, disclosing legal reasoning funds to keep state cannabis “within the meaning” of Section 280E — taxpayer scrutiny remains the same.

However, whether substantively or psychologically, these recent developments weigh on how taxpayers should deal with Section 280E. Below, we summarize the key developments that cannabis taxpayers should be aware of as they prepare their 2025 returns.

As discussed in previous publications, Section 280E provides: “(e) no deduction or credit shall be allowed for any amount paid or incurred in the course of any trade or business during the taxable year, if such trade or business (or the activities constituting such trade or business) is trafficking in controlled substances (controlled substance classes I and II prohibited by State or Federal law).

Because cannabis is now listed as a Schedule I controlled substance under the Controlled Substances Act (CSA), the IRS has consistently maintained that Section 280E applies to state-licensed cannabis businesses, significantly increasing their effective tax rates.

Read more at JD above










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media